Navigation Links
European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
Date:6/16/2008

e clopidogrel and aspirin; the other half will receive CGT-2168 (clopidogrel plus omeprazole) and aspirin. Patients will be assessed regularly for any gastrointestinal side effects such as bleeding and ulcers as well as receive ongoing monitoring of their cardiovascular status.

"This is yet another important milestone for our company," said Cogentus Chairman and Chief Executive Officer Mark A. Goldsmith, M.D., Ph.D. "COGENT has been very well received by the medical community in North America, with strong enrollment. Now we will begin to gather important data from investigators in Europe and broaden the patient base of the study."

ABOUT COGENTUS

Cogentus Pharmaceuticals, Inc., of Menlo Park, CA, is a privately held specialty pharmaceutical company founded in 2006. Cogentus (http://www.cogentus.net) is committed to becoming a premier developer of innovative, fixed-dose combination prescription medicines serving unmet medical needs that drive significant commercial opportunities.

COGENT stands for Clopidogrel and the Optimization of Gastrointestinal Events Trial. In addition to North America and Europe, the COGENT program also will include patients in South America, where clinical sites are expected to come on line later this year.

Plavix(R) is a registered trademark of Sanofi-Aventis.


'/>"/>
SOURCE Cogentus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. XTENT Announces European Regulatory Update
2. Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
3. Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings
4. European Unions CHMP Issues Positive Opinion on Sugammadex
5. PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM)
6. PRoFESS(R) Results Announced at XVII European Stroke Conference
7. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
8. Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
9. European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina
10. More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL
11. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire-iReach/ -- MedicOne Medical ... transport services, has been selected by Inc. Magazine ... in America. Photo - ... 500|5000 list identifies successful, privately-held companies with the ... Medical Response, one of only two ambulance companies ...
(Date:9/15/2014)... , Sept. 15, 2014  Catalist-listed QT Vascular Ltd. ... a developer and manufacturer of minimally invasive medical devices ... announce that the Group has enrolled the first European ... . Multiple patients have already been enrolled in ... Auckland City Hospital, in Auckland, New Zealand ...
(Date:9/15/2014)... NEW YORK , Sept. 15, 2014 /PRNewswire/ ... together under one roof Saturday to learn, interact ... treatments at New York City,s first Lupus Trials Fair ... (LRI) and the S.L.E. Lupus Foundation . ... NYC,s leading institutions -- sharing experiences, ideas and ...
Breaking Medicine Technology:MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 3First European Patients Enrolled in QT Vascular's ENDURE Trial 2First European Patients Enrolled in QT Vascular's ENDURE Trial 3First European Patients Enrolled in QT Vascular's ENDURE Trial 4First European Patients Enrolled in QT Vascular's ENDURE Trial 5Lupus Research Institute Launches NYC's First Lupus Trials Fair 2Lupus Research Institute Launches NYC's First Lupus Trials Fair 3
(Date:9/16/2014)... Syracuse, NY (PRWEB) September 16, 2014 ... HearStrong Champion Danielle Strassle at the 2014 Buffalo Bills ... in Buffalo, NY. , Bills legend and NFL ... , assisted the foundation in honoring Strassle for her ... and professional goals and inspire others in her community ...
(Date:9/16/2014)... Online retailer Kettlebell Kings has announced that ... kettlebell purchases in their online store. The company wants ... with this effective workout method that is quickly gaining ... carries a variety of kettlebell brands as well as ... , “We’ve seen for ourselves how effective kettlebells ...
(Date:9/16/2014)... Yellow Spings, OH (PRWEB) September 16, 2014 ... the Master of Arts in Clinical Mental Health ... offering joins a growing list of programs offered through ... the spring semester starting January 2015. , "Antioch University ... a strong reputation in the field and a track ...
(Date:9/16/2014)... Issaquah, WA (PRWEB) September 16, 2014 ... of medical equipment and supplies and a veteran-owned ... lines for medical professionals-- Jant Pharmacal Corporation, Nipro ... is committed to providing its customers the best, ... serve its current customers, and in an effort ...
(Date:9/16/2014)... The Living Ethics lecture series returns ... on what it means to live in an ethically ... and thought-provoking topics. , “The Museum’s job is to ... at their world differently. The Living Ethics series’ ... truly enlightening dialogue,” says Richard Conti, Chief Wonder Officer, ...
Breaking Medicine News(10 mins):Health News:The HearStrong Foundation and the Buffalo Bills Alumni Foundation Celebrated HearStrong Champion During 2014 Alumni Weekend 2Health News:Join the Kettlebell Movement - Kettlebell Kings Announces $0 Shipping on all Orders 2Health News:Antioch University Launches Online Master’s Degree Program in Clinical Mental Health Counseling 2Health News:Expanding Community Vision at the Science Museum of Virginia 2
... A recent study finds that, TACE inhibitors currently developed ... control proliferation of tumor cells. TACE is// strongly present ... to current therapies. ,TACE (tumor necrosis factor-alpha-converting ... pair of ligands, called Amphiregulin and TGF-alpha, from the ...
... states have registered a leap in the number of dengue ... authorities fearing that the mosquito-borne// disease could further spread due ... ,The north-eastern state of Kelantan registered the highest jump, from ... cases in the first week of January. ...
... and Drug Administration has given the go-ahead to the ... otherwise called fat loss,// occurring in patients with AIDS ... assist in the manufacture of collagen. ,To ... on a study of 100 HIV patients suffering facial ...
... worried about the lack of natural B vitamin "folate" in ... has linked the inadequacy of this vitamin to birth defects ... to breads and cereals being supplemented with folic acid. This ... nation-wide study, undertaken between 1999 and 2004 showed that more ...
... by Jane Carlton, Ph.D., a parasite specialist and an associate ... University// School of Medicine, have successfully decoded the genome of ... STD that usually affects both men and women. ... of the journal Science. ,Moreover, this 4-year ...
... to a British Muslim scholar a special and specific health ... of Edinburgh University// believes that this could hold the key ... ,While sharing his thoughts in the British Medical Journal, professor ... realize this need and bring about a change in the ...
Cached Medicine News:Health News:A New Strategy to Control Breast Cancer 2Health News:Mosquito-borne Dengue Disease on the Rise in Five Malaysian States 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: